Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors. - Kahn AM; Perry CJ; Etts K; Kluger H; Sznol M (The oncologist, 2024)